COVID-19 antibody / Evotec - LARVOL DELTA

"Evotec's new Washington site is ready to roll, and the U.S. has already called first dibs for COVID-19 antibody supplies https://t.co/cjw8s4FK3Y" (@FiercePharma)

Infectious Disease • Novel Coronavirus Disease

Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies (Issuer Direct) - "Evotec SE...announced that the U.S. Department of Defense ('DOD') awarded its Seattle, Washington-based subsidiary, Just - Evotec Biologics, Inc., an agreement worth $28.6 million for the production of monoclonal antibodies ('mAbs') for use in the development of a treatment and/or prophylaxis for COVID-19....DOD will have access to pivotal manufacturing capacity for anti-SARS-CoV-2 mAbs and priority access to future biomanufacturing capacity over a period of seven years in the soon-to-be-completed J.POD(R) facility in Redmond, Washington. The agreement represents the continuation of DOD's collaboration with Just - Evotec Biologics."

Commercial • Infectious Disease • Novel Coronavirus Disease